Electro-mechanical (dys-)function in long QT syndrome type 1

Int J Cardiol. 2019 Jan 1:274:144-151. doi: 10.1016/j.ijcard.2018.07.050. Epub 2018 Jul 9.

Abstract

Background: Prolonged repolarization is the hallmark of long QT syndrome (LQTS), which is associated with subclinical mechanical dysfunction. We aimed at elucidating mechanical cardiac function in LQTS type 1 (loss of IKs) and its modification upon further prolongation of the action potential (AP) by IKr-blockade (E-4031).

Methods: Transgenic LQT1 and wild type (WT) rabbits (n = 12/10) were subjected to tissue phase mapping MRI, ECG, and epicardial AP recording. Protein and mRNA levels of ion channels and Ca2+ handling proteins (n = 4/4) were determined. In silico single cell AP and tension modeling was performed.

Results: At baseline, QT intervals were longer in LQT1 compared to WT rabbits, but baseline systolic and diastolic myocardial peak velocities were similar in LQT1 and WT. E-4031 prolonged QT more pronouncedly in LQT1. Additionally, E-4031 increased systolic and decreased diastolic peak velocities more markedly in LQT1 - unmasking systolic and diastolic LQT1-specific mechanical alterations. E-4031-induced alterations of diastolic peak velocities correlated with the extent of QT prolongation.

Conclusion: While baseline mechanical function is normal in LQT1 despite a distinct QT prolongation, further prolongation of repolarization by IKr-blocker E-4031 unmasks mechanical differences between LQT1 and WT with enhanced systolic and impaired diastolic function only in LQT1. These data indicate an importance of the extent of QT prolongation and the contribution of different impaired ion currents for conveying mechanical dysfunction.

Keywords: Electro-mechanical dysfunction; Genotype differences; I(Kr)-blockade; Long QT syndrome; Tissue-phase mapping cardiac MRI.

MeSH terms

  • Action Potentials / drug effects
  • Action Potentials / physiology*
  • Animals
  • Animals, Genetically Modified
  • Anti-Arrhythmia Agents / pharmacology
  • Biomechanical Phenomena
  • Disease Models, Animal
  • Electrocardiography / methods*
  • Magnetic Resonance Imaging, Cine
  • Male
  • Myocardial Contraction / drug effects
  • Myocardial Contraction / physiology*
  • Myocytes, Cardiac / metabolism
  • Myocytes, Cardiac / pathology
  • Piperidines / pharmacology
  • Pyridines / pharmacology
  • Rabbits
  • Romano-Ward Syndrome / diagnosis
  • Romano-Ward Syndrome / drug therapy
  • Romano-Ward Syndrome / physiopathology*

Substances

  • Anti-Arrhythmia Agents
  • Piperidines
  • Pyridines
  • E 4031